-
公开(公告)号:US20250019696A1
公开(公告)日:2025-01-16
申请号:US18260789
申请日:2022-11-17
Applicant: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventor: Zhihong JIANG , Yuan MA , Fei REN
IPC: C12N15/113 , A61K36/074 , A61P11/06
Abstract: A use of ganoderma fungal RNA molecules, a drug, a drug composition and a delivery carrier are provided. It has been proved that the tRFs derived from the ganoderma traditional Chinese medicine has an obvious inhibiting effect on airway smooth muscle cell phenotype change (proliferation, abnormal secretion and the like) induced by TGF-β1 and AHR, inflammation and remodeling of asthma mice induced by Dermatophagoides pteronyssinus in the experiments of the present disclosure, which suggests that the tRFs derived from the ganoderma traditional Chinese medicine and a pharmaceutical composition can be a brand new medicine for treating asthma. The drug comprises the RNA molecule and a pharmaceutically acceptable carrier, diluent and/or excipient. The present disclosure is helpful for the research and development of asthma treatment drugs and provides reference for the research and development of other respiratory system disease treatment drugs.
-
公开(公告)号:US20220127220A1
公开(公告)日:2022-04-28
申请号:US17110567
申请日:2020-12-03
Applicant: Macau University of Science and Technology
Inventor: Zhi-Hong Jiang , Nanshan Zhong , Zifeng Yang , Jingrong Wang , Qitong Feng , Xiaobo Zhou , Beixian Zhou
IPC: C07C233/87
Abstract: A compound including a structure of Formula (I) and a preparation method thereof, wherein R1 is —OH, —CH2OH, or —OCOCH3; R2, R3, and R4 are independently —H, —CH3 or —F, and at least one of R2, R3, and R4 is —F. A method for treating a subject suffering from a viral disease includes administering an effective amount of said compound or a solvate thereof to the subject.
-
公开(公告)号:US10580150B2
公开(公告)日:2020-03-03
申请号:US15894956
申请日:2018-02-13
Applicant: Macau University of Science and Technology
Inventor: Zhanchuan Cai , Wei Cao
Abstract: Example embodiments include a method that improves calculations of surface roughness that map a planetary surface. The method includes calculating a V-system matrix with a size of α×α in an interval [0,1]; transforming the V-system matrix into an orthogonal matrix; improving calculations of the surface roughness of the planetary surface by calculating the surface roughness of a digital elevation model generated from data captured from the planetary surface; and generating a map of the planetary surface based on the surface roughness.
-
4.
公开(公告)号:US20190244104A1
公开(公告)日:2019-08-08
申请号:US15886860
申请日:2018-02-02
Applicant: Macau University of Science and Technology
Inventor: Zhanchuan Cai , Aiju Li
CPC classification number: G06N3/084 , G06F17/156 , G06F17/16
Abstract: One embodiment is a method that improves computations of correlation values between a surface roughness and terrain parameters of a terrain surface. The method includes applying the terrain parameters as an input of a Back Propagation Neural Network (BPNN) and the surface roughness as an output of the BPNN; implementing a nonlinear mapping from the input to the output of the BPNN; generating a weight matrix (ω1) and a weight matrix (ω2); and improving computations of the correlation values by calculating a correlation matrix by ω2×ω1, calculating a unit weight which is a sum of absolute values in the correlation matrix, and dividing each value in the correlation matrix by the unit weight.
-
公开(公告)号:US10342777B2
公开(公告)日:2019-07-09
申请号:US14872198
申请日:2015-10-01
Applicant: Macau University of Science and Technology
Inventor: Pei Luo , Zhifeng Zhang , Hao Zhang
IPC: A61K31/357 , A61K31/216 , A61K36/28
Abstract: A caffeoylquinic acid-rich extract obtained from Erigeron multiradiatus and a method for producing the same. A caffeoylquinic acid-rich extract includes at least 15% by weight of a mixture of certain caffeoylquinic acids. The extract with the mixture of caffeoylquinic acids is highly efficacious in treating and preventing myocardial ischemia or myocardial ischemia reperfusion injuries. A method for treating or preventing a disease caused by myocardial ischemia or myocardial ischemia reperfusion includes administering a therapeutically effective amount of the caffeoylquinic acid-rich extract to a subject. Pharmaceutical compositions including the caffeoylquinic acid-rich extract are also disclosed.
-
公开(公告)号:US10332279B2
公开(公告)日:2019-06-25
申请号:US15448591
申请日:2017-03-03
Applicant: Macau University of Science and Technology
Inventor: Zhanchuan Cai , Ting Lan
Abstract: A method constructs an image with improved peak signal-to-noise ratio (PSNR) from a scattered pixel set. The method generates an approximation function that is a linear combination of a plurality of Many-Knot (MK) spline basis functions, and constructs the image with improved PSNR by conducting a least squares treatment on the approximation function to minimize a residual of each pixel value in the scattered pixel set from the approximation function.
-
公开(公告)号:US10296999B2
公开(公告)日:2019-05-21
申请号:US15431739
申请日:2017-02-13
Applicant: Macau University of Science and Technology
Inventor: Zhanchuan Cai
IPC: H04L9/00 , G06T1/00 , H04N19/467 , H04N1/32
Abstract: A method embeds a watermark image into a host image with adaptive rectangular partition and Lower Upper (LU) decomposition such that a watermarked image is generated with improved computational complexity. The method divides a host image into an Red (R) component, a Green (G) component, and a Blue (B) component, and divides each component of the R, G, and B components into a plurality of M×M size blocks, and partitions each of the plurality of M×M size blocks into a plurality of non-overlapping blocks with adaptive rectangular partition. The method selects a plurality of embedding blocks from the plurality of M×M size blocks for each component of the R, G, and B components of the host image to embed watermark information such that the watermarked image is generated.
-
公开(公告)号:US10278955B1
公开(公告)日:2019-05-07
申请号:US15839875
申请日:2017-12-13
Applicant: Macau University of Science and Technology
Inventor: Xiao Jun Yao , Lai Han Elaine Leung , Liang Liu , Qian Qian Wang , Jia Hui Xu , Ying Li
IPC: A61K31/4045 , A61P35/00 , G01N33/574 , A61K45/06
Abstract: One embodiment is a method of treating cancer. The method includes administering a therapeutically effective amount of a compound to a patient. The compound is represented by Formula I:
-
公开(公告)号:US10260114B2
公开(公告)日:2019-04-16
申请号:US15598434
申请日:2017-05-18
Inventor: Jin-Xiang Chen , Bin Sun , Bao-Ping Xie , Zhi-Hong Jiang , Li-Ping Bai
IPC: C07D213/50 , C12Q1/70 , C12Q1/6818 , C08G79/00
Abstract: The present invention relates in a first aspect to a method of preparing a crystalline lanthanum-carboxylate coordination polymer and the crystalline lanthanum-carboxylate coordination polymer obtained or obtainable by the method. In another aspect of the present invention, also provides a method of detecting a target nucleic acid sequence in a sample.
-
公开(公告)号:US20190060273A1
公开(公告)日:2019-02-28
申请号:US15682564
申请日:2017-08-22
Applicant: Macau University of Science and Technology
IPC: A61K31/357 , A61K31/352 , A61K9/00 , A61K9/20
Abstract: One example embodiment relates to a method of increasing bioavailability of silybin in a person. The method includes providing silybin and a flavonoid to the person, wherein the flavonoid is tangeretin or baicalein. Another example embodiment relates to a method of treating chronic liver disease in a person by administering silybin and a flavonoid to the person to treat the chronic liver disease.
-
-
-
-
-
-
-
-
-